Becton Dickinson and Company (BDX-RM)

20,488.00
+328.00(+1.63%)
  • Volume:
    4
  • Bid/Ask:
    20,448.00/20,488.00
  • Day's Range:
    20,200.00 - 20,488.00
  • Type:Equity
  • Market:Russia
  • ISIN:US0758871091

BDX-RM Overview

Prev. Close
20,160
Day's Range
20,200-20,488
Revenue
-
Open
20,200
52 wk Range
16,814-20,488
EPS
-
Volume
4
Market Cap
5.84T
Dividend (Yield)
3.48
(N/A)
Average Vol. (3m)
188
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
285,043,370
Next Earnings Date
-
What is your sentiment on Becton Dickinson and Company?
or
Market is currently closed. Voting is open during market hours.

Becton Dickinson and Company Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Can someone tell me the difference between this stock and AMBU(danish company). Becides the fact that AMBU is valued 1/5 of BDX…
    0
    • anyone an idea for a target?
      0
      • $240
        0
    • https://www.fool.com/investing/2021/02/27/these-3-stocks-big-winners-from-president-biden/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
      0
      • Last chance to get in , DPA will give a big boost in a few weeks.
        1
        • Rajeesh Raju good luck
          0
        • Lode Schepershttps://www.nasdaq.com/articles/becton-dickinson-gets-eua-for-new-diagnostic-test-2021-02-14
          0
        • Rajeesh Raju Thank you very much. Succes!
          0
      • bye bye b d x you stepped on Elon Musk toes
        2
        • what happened ?
          0
      • https://www.biospace.com/article/releases/cardiff-oncology-prices-public-offering-sep-30-2020/
        0
        • 300$ by end of 2020
          1
          • We need to see at least 230 before its worth getting into.
            2
            • insane earnings, insane share price, insane P/E ratio
              0
              • P/E isn't insane, 91 is without NRI, forward P/E is 20. At 15 it would be a good entry point but the price would have to be $180.
                0
            • . I want to know if this asset comes in at 192 this week? What do you guys think?
              0
              • I would pull the trigger at $180 with a forward P/E of 15.
                0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.